Pearl, the global leader in dental AI solutions, and Patterson Dental Canada, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), announced a collaboration to expand access to Pearl’s Second Opinion AI disease detection capabilities within the Canadian dental market.
Pearl’s real-time pathology detection AI software, Second Opinion, assists dentists in their radiologic evaluation and case presentation of dental conditions commonly found in dental x-rays, including caries, bone loss, calculus, and more. The technology, which received its Medical Device Establishment License (MDEL) from Health Canada in 2021, enables dentists to read patient x-rays more accurately and efficiently, enhancing their clinical performance and patient communication.
“For decades, Patterson Dental Canada has been committed to providing tailored solutions that meet the dental industry’s rapidly evolving needs,” said Dan Begin, Region President of Patterson Dental Canada. “Pearl’s innovative AI-backed technology has set a new standard of care within dentistry. By adding Pearl’s AI to our leading dental software offerings, we are furthering our commitment to enabling the most advanced dental care across thousands of Canadian dental practices.”
The announcement marks an expansion of Pearl’s commercial ties with Patterson Companies, Inc. In November 2023, Pearl and Patterson Dental Supply, Inc. established an integration with Pearl’s AI feature set natively within Patterson’s Eaglesoft, Fuse, and Dolphin practice management software platforms. By expanding Second Opinion access in Canada, Pearl’s connection with Patterson Dental Canada makes the benefits of advanced clinical AI available to every Patterson Dental customer across North America.
“Patterson Dental Canada is one of the most trusted names in dental technology,” said Ophir Tanz, founder and CEO of Pearl. “We are proud to work together in advancing our mission to elevate the global standard of care in dentistry.”
